- Slocombe B, Basker M, Benthley PH et al. BRL 17421, a novel β-lactam antibiotic highly resistant to β-lactamases, giving high and prolonged serum levels in humans. J Anlimicrob Agents Chemother. 1981; 20: 38–46.
- Van Landuyt HW, Muckavet M, Lambert A, Boelaert J. In vitro activity of temocillin (BRL 17421), a novel β-lactam antibiotic. J Antimicrob Agents Chemother. 1982; 22: 535–44.
- Brown RM, Wise R, Andrews JM. Temocillin, in vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers. J Anlimicrob Chemother. 1982; 10: 295–302.
- Boelaert J, Daneels R, Schurgers M et al. The pharmacokinetics of temocillin in patients with normal and impaired renal function. J Antimicrob Chemother. 1983; 11: 349–56.
- Leroy A, Humbert G, Fillastre JP, Borsa F, Godin M. Pharmacokinetics of temocillin (BRL 1742) in subjects with normal and impaired renal function. J Antimicrob Chemother. 1983; 12: 47–58.
- Uwaydah M, Najjar F, Vartivaria S, Harakeh H. Temocillin bile levels. J Antimicrob Chemother. 1983; 14: 193–4.
- De Vries-Hospers HG, Hofstra W, Welling GW. The influence of BRL 17421 (temocillin) on the intestinal flora of mice and man; usefulness for selective decontamination ? Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami, p. 201 American Society for Microbio logy, Washington DC 1982.
- Libert M, Schulman CC. Treatment of urinary tract infections with temocillin. Curr Ther Res. 1983; 33: 887–91.
- Proceedings of a symposium on temocillin. Guest Edits H. Lode, L. Verbist, JD Williams. Drugs. 1985; 19: suppl. 5, 243 pp.
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 40, 1985 - Issue 6